Skip to main content
CDRE $34.14 +0.71%
CDRE logo

CDRE · Cadre Holdings, Inc.

Track CDRE — free
$34.14 +0.24 (+0.71%) At close · Aug 14
Market Cap
$1.46B
Shares
42.82M
All earnings calls

Earnings call · FY2025 Q4

Cadre Holdings, Inc. Q4 FY2025 Earnings Call

Cadre Holdings, Inc. Q4 FY2025 Earnings Call

Concluded Mar 11, 2026 Audio replay
Mar 11, 2026 43:06 45 turns
Period
FY2025 Q4
Runtime
43:06
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Cadre Holdings reported FY2025 net sales of $610.3M with record adjusted EBITDA of $111.7M for a third consecutive year, and guided FY2026 net sales of $736–$758M (+22% YoY at midpoint) and adjusted EBITDA of $136–$141M (+24% YoY at midpoint) following the close of the TIER Tactical acquisition.

Organic growth outlook and guidance 19 M&A and acquisitions 16 Nuclear safety market 11 International growth and large opportunities 10 Operational integration 9 Blast mitigation and sensor technologies 8

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “Fiscal 2025 was another year of steady progress for Cadre Holdings, Inc.”
  • “Our team secured a number of meaningful contract wins during the year, particularly in advanced sensor technologies and blast mitigation seating, areas where performance and reliability are essential.”
  • “Orders backlog was up significantly. 2025 order growth plus the addition of CARS Engineering division in April results in a nearly 50% increase in our backlog versus last year.”
  • “We delivered on our strategic objectives in the fourth quarter, driven by strong and recurring demand for our mission-critical safety products combined with the continued implementation of our operating model.”

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $167.22M -5% YoY
Gross margin · derived Q4 43.4% -0.5 pp YoY
Net income · derived Q4 $11.74M -9.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • FY2025 net sales of $610.3M and net income of $44.1M ($1.02 diluted EPS) with full-year gross margin of 42.5% and adjusted EBITDA margin of 18.3%.
  • Record annual adjusted EBITDA of $111.7M, achieved for the third consecutive year.
  • FY2026 guidance of $736–$758M net sales and $136–$141M adjusted EBITDA, representing ~22% and ~24% YoY growth at midpoints, respectively.
  • Orders backlog up nearly 50% versus prior year, including the $50M BMO IDIQ contract with the U.S. military.
  • Closed TIER Tactical acquisition, adding advanced protective equipment capabilities and international market access.
  • Quarterly dividend raised to $0.10/share ($0.40 annualized), a 5.3% per-share increase and the 17th consecutive quarterly dividend since IPO.

Risks & pressure points

  • Q1 2026 revenue expected roughly in line with Q3 2025 ($155.8M), with gross margin ~39% and adjusted EBITDA margin in the low teens, implying a sequential step-down from Q4 2025's 43.4% gross margin and 20.6% adjusted EBITDA margin.
  • Q4 2025 backlog declined sequentially versus Q3 due to large international duty gear orders shipping out and other large shipments, partially offsetting the YoY backlog growth.
  • Some larger opportunities remain unclosed and are expected to continue progressing through 2026, creating near-term visibility risk.
  • Nuclear environmental cleanup work is a headwind to 2026 organic backlog growth that must be offset by commercial nuclear wins.
  • TIER synergy assumptions are not included in guidance, and transaction costs carry over into Q1 2026.

Key moments

Jump directly to management's words in the synchronized transcript.

“Orders backlog was up significantly. 2025 order growth plus the addition of CARS Engineering division in April results in a nearly 50% increase in our backlog versus last year. This includes the blast exposure monitoring system, or BMO, contract that we discussed last quarter. As a reminder, this is a $50 million IDIQ contract and represents a major achievement for our team and a key milestone in our work with the U.S. military.” Speaker 3, Other

Forward guidance

From the 8-K filed Mar 10, 2026.

Metric Guided
Net sales
full year 2026
$736M – $758M
Adjusted EBITDA
full year 2026
$136M – $141M
Capital expenditures
full year 2026
$10M – $14M

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.10
Full-screen source Call document